Canntrust Holdings Inc. (TRST-T) Stock Predictions - Stockchase
WATCH LIST
9
Canntrust Holdings Inc. (TRST-T)

ON STOCKCHASE SINCE May 2018

0

Canntrust Holdings Inc.

TRST-T

18 watching          
Join the Discussion

Canntrust Holdings Inc. (TRST-T) SAVE Apr, 19, 2019, 7:40 am

9.42 0.24 (2.48%)

What the experts are saying about TRST-T



  • All
  • Filtered
Signal Opinion Expert
BUY
He started researching the cannabis sector because he thought cannabis was a pump-and-dump play--and it's largely true. The ones who'll make lasting money in this space are the insiders who sold stock and their investment bankers. He's owned TRST the past 9 months. Research said that TRST tells the truth and is well-financed, and a low-cost operator with modern operations. Yes, it's been frustrating because TRST tells the truth and they do what they say they'll do. They're about to list in New York, but keep in mind who their investment bankers will be. This listing will attract Canadian coverage from banks, as well as from BAC and GS in the U.S. This will raise their profile and shareholder base a lot. A well-run company that wants to build sustainably for the long run.
0 0 0 0 0
0 comments
He started researching the cannabis sector because he thought cannabis was a pump-and-dump play--and it's largely true. The ones who'll make lasting money in this space are the insiders who sold stock and their investment bankers. He's owned TRST the past 9 months. Research said that TRST tells the truth and is well-financed, and a low-cost operator with modern operations. Yes, it's been frustrating because TRST tells the truth and they do what they say they'll do. They're about to list in New York, but keep in mind who their investment bankers will be. This listing will attract Canadian coverage from banks, as well as from BAC and GS in the U.S. This will raise their profile and shareholder base a lot. A well-run company that wants to build sustainably for the long run.
0
0 0 0 0 0
0 comments
John O'Connell,

Chairman a, Davis Rea...

Price Price
$10.150
Owned Owned
Yes

HOLD
They are working on a US listing. It is a cannabis stock that is hoping to get better US multiples. He thinks they might be taken out going forward. They have international expansion and are growing in Canada. They trade at a discount to the larger peer group in the space. He owns it and thinks it goes higher.
0 0 0 0 0
0 comments
They are working on a US listing. It is a cannabis stock that is hoping to get better US multiples. He thinks they might be taken out going forward. They have international expansion and are growing in Canada. They trade at a discount to the larger peer group in the space. He owns it and thinks it goes higher.
0
0 0 0 0 0
0 comments
Bruce Campbell

President , Stone Castle Investm...

Price Price
$9.220
Owned Owned
Yes

WATCH
Frustrated by it. Still owns it. When they bought it they thought that they had a solid business case. They just hired a new CEO. The Member of the Board continue to sell stocks and that is not a good sign but the profits and financials are very strong. He thinks there are going to be joint ventures in the US and internationally. They reported real revenue growth. The company needs to make changes at the Board level.
0 0 0 0 0
0 comments
Frustrated by it. Still owns it. When they bought it they thought that they had a solid business case. They just hired a new CEO. The Member of the Board continue to sell stocks and that is not a good sign but the profits and financials are very strong. He thinks there are going to be joint ventures in the US and internationally. They reported real revenue growth. The company needs to make changes at the Board level.
0
0 0 0 0 0
0 comments
John O'Connell,

Chairman a, Davis Rea...

Price Price
$7.400
Owned Owned
Yes

BUY
A past top pick. From a pure valuation perspective he likes it and it trades at 7 times EBITA compared to competitors that trade at 30 times. They have taken a medical approch to their company and have a distribution agreement into Germany. They are involved in a brew-buds technology for the US. He is surprised of the recent sell off and attributes it to the delay in getting a US listing. He owns it and still likes it.
0 0 0 0 0
0 comments
A past top pick. From a pure valuation perspective he likes it and it trades at 7 times EBITA compared to competitors that trade at 30 times. They have taken a medical approch to their company and have a distribution agreement into Germany. They are involved in a brew-buds technology for the US. He is surprised of the recent sell off and attributes it to the delay in getting a US listing. He owns it and still likes it.
0
0 0 0 0 0
0 comments
Bruce Campbell

President , Stone Castle Investm...

Price Price
$7.780
Owned Owned
Yes

TOP PICK

This company was founded by pharmacists who is globally focused in generic drug manufacturing in 115 countries.  They win 38% of new patients added to new medical cannabis users.  They hire doctors to educate doctors about medical usages.  Yield 0%.  (Analysts’ price target is $16.93)

0 0 0 0 0
0 comments

This company was founded by pharmacists who is globally focused in generic drug manufacturing in 115 countries.  They win 38% of new patients added to new medical cannabis users.  They hire doctors to educate doctors about medical usages.  Yield 0%.  (Analysts’ price target is $16.93)

0
0 0 0 0 0
0 comments
Charles Taersk

President , Faircourt Asset Mana...

Price Price
$13.670
Owned Owned
Yes

TOP PICK

They have done a great job.  They are in the top three as far as medical patients go.  It is super cheap.  They are talking about a US listing and that could light it on fire.  They could get taken over.  (Analysts' target; $16.11).

0 0 0 0 0
0 comments

They have done a great job.  They are in the top three as far as medical patients go.  It is super cheap.  They are talking about a US listing and that could light it on fire.  They could get taken over.  (Analysts' target; $16.11).

0
0 0 0 0 0
0 comments
Bruce Campbell

President , Stone Castle Investm...

Price Price
$12.040
Owned Owned
Yes

BUY
Canntrust Holdings Inc.(TRST-T) 

September 10, 2018

ACB-T vs. APH-T.  The sector is highly volatile.  APH-T is possibly a little higher quality and there have been rumours around them getting a large investment from a strategic player.  TRST-T is the one he holds and is the best way to play this sector.

0 0 0 0 0
0 comments

ACB-T vs. APH-T.  The sector is highly volatile.  APH-T is possibly a little higher quality and there have been rumours around them getting a large investment from a strategic player.  TRST-T is the one he holds and is the best way to play this sector.

0
0 0 0 0 0
0 comments
Colin Stewart

CEO & Port, JC Clark Investments...

Price Price
$11.750
Owned Owned
Yes

COMMENT

This is a relatively small cannabis player but the trailing EBITDA is minimal and the forecasted earnings are speculative. He bought the IPO at $2 and sold it at $4. It’s one of the higher quality companies in the space, with interesting value add ideas. They even have a patent for infused cannabis in Keurig cups.

0 0 0 0 0
0 comments

This is a relatively small cannabis player but the trailing EBITDA is minimal and the forecasted earnings are speculative. He bought the IPO at $2 and sold it at $4. It’s one of the higher quality companies in the space, with interesting value add ideas. They even have a patent for infused cannabis in Keurig cups.

0
0 0 0 0 0
0 comments
James Hodgins

Chief Inve, Curvature Hedge Stra...

Price Price
$9.660
Owned Owned
No

DON'T BUY

 This is a cannabis company that has a new product line for pets.  He generally dislikes the sector and the associated valuations.   You are betting this sector is going to explode and it is hard to know which companies will survive.  It has a $600 million valuation on $20 million in sales. 

0 0 0 0 0
0 comments

 This is a cannabis company that has a new product line for pets.  He generally dislikes the sector and the associated valuations.   You are betting this sector is going to explode and it is hard to know which companies will survive.  It has a $600 million valuation on $20 million in sales. 

0
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$7.350
Owned Owned
No

Showing 1 to 9 of 9 entries
Successfully Saved Company
Successfully Saved Company
4+
JOIN THE DISCUSSION
4 comments in the last 7 days